× We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click our cookies policy for information on how to change your cookie settings.


meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19

tutorial video
En     Fr

Our approach


adjuvant therapies

anticoagulant 2

anticoagulant, curative dose 5

anticoagulant, pre-admission 3

anticoagulant, prophylactic dose 4

anticoagulation, intermediate prophylactic dose 1

Bivalirudin

enoxaparin

heparin at therapeutic dose

prasugrel

sulodexide

face mask

febuxostat

hydrogen-oxygen nebulizer

hyperbaric oxygen

nintedanib

pulmonary rehabilitation

anti-inflammatoty and immuno-therapy

acalabrutinib 2

anti-inflammatory therapies 1

colchicine 6

IFX-1

mavrilimumab 1

naproxen, ibuprofen

non-steroidal anti-inflammatory drugs 8

Celecoxib 1

Ibuprofen 1

Indomethacin 1

sodium aescinate

Apilimod

corticosteroids 7

ciclesonide

dexamethasone 5

Dexamethasone 12mg 1

Hydrocortisone 4

low-dose corticosteroids

methylprednisolone 6

imatinib 1

Immunostimulants drugs

anti-PD-1 antibody

CD24Fc

convalescent plasma treatment 28

Early convalescent plasma. 1

immunoglobulin therapy 4

emapalumab

inactivated mycobacterium vaccine

interferon 1

IFN beta-1a 3

high-dose IFN beta-1a 1

IFN beta-1b 2

IFN gamma 1

inhaled interferon

recombinant super-compound interferon rSIFN-co 1

SNG001 inhaled interferon beta 1

interferon / TFF2 1

peginterferon 3

PNB001

Interleukin-2

neutralizing antibody

AZD7442

bamlanivimab monotherapy 2

bamlanivimab plus etesevimab 3

BRII-196 and BRII-198 (Brii Biosciences)

casirivimab and imdevimab (REGN-COV2) 2

equine polyclonal antibodies INM005 1

LY-CoV1404

regdanvimab (CT-P59 Celltrion) 1

sotrovimab (VIR-7831) 2

rhG-CSF

Vitamin D 7

Immunosuppressants drugs

anakinra 2

anti-interleukin-6

clazakizumab

sarilumab 4

sarilumab azithromycin hydroxychloroquine

sarilumab high dose (400mg) 1

sarilumab low dose (200mg) 1

siltuximab

tocilizumab 28

canakinumab 1

complement inhibitors

eculizumab

itolizumab 1

jakotinib

janus kinase (JAK) inhibitor

baricitinib 2

tofacitinib 1

lenzilumab 1

ruxolitinib 2

tacrolimus

tetrandrine

inhaled corticosteroids

budesonide 2

leflunomide 1

meplazumab

pirfenidone

Polyinosinic-Polycytidylic Acid

sargramostim

thymosin

antiandrogenic

5-alpha-reductase inhibitors

dutasteride 1

proxalutamide 3

antiviral and associated therapy

ASC09/ritonavir

azithromycin 10

azithromycin plus hydroxychloroquine 3

azvudine 1

baloxavir marboxil 1

carrimycin

chloroquine and derivatives 1

chloroquine 5

hydroxychloroquine 44

danoprevir / ritonavir

darunavir cobicistat 1

darunavir/cobicistat plus chloroquine

doxycycline 2

favipiravir 16

favipiravir plus interferon 1

fluvoxamine 2

hydroxychloroquine plus macrolides 8

ivermectin 24

ivermectin plus doxycycline 3

leronlimab

lopinavir / ritonavir plus ribavirin

lopinavir/ritonavir 9

lopinavir/ritonavir plus interferon ß-1a 1

lopinavir/ritonavir, ribavirin and interferon beta-1b 1

nitazoxanide 4

opaganib

oseltamivir 1

oseltamivir plus chloroquin

remdesivir 9

Renin-angiotensin-system-acting agents 7

angiotensin converting enzyme inhibitors (ACEIs)

angiotensin receptor blockers (ARBs) 3

losartan 1

angiotensin-(1-7)

discontinuation of ACEI/ARB 3

RAS blocker withdrawal

rhACE2

ritonavir

sofosbuvir 2

sofosbuvir and daclatasvir 5

sofosbuvir and ledipasvir 2

tenofovir/emtricitabine 1

tranexamic acid

triazavirin

umifenovir (arbidol) 5

clarithromycine 2

control

prone positioning

honey

miscellaneous

2-deoxy-D-glucose (2-DG)

acetylcysteine

alpha lipoic acid 1

aviptadil

bevacizumab

bismuth

BLD-2660 (calpain inhibitor)

bromhexine 3

calcium channel blocker

camostat mesilate 1

continuous positive airway pressure (CPAP)

cytokine adsorption

dapagliflozin 1

diammonium glycyrrhizinate

dipyridamol

DPP-4 inhibitor

kinin-kallikrein inhibitors

levamisole

metformin

natural killer (NK) cells

nicotin

nitric oxide (gas Inhalation or releasing solution)

ozonated autohemotherapy

pamrevlumab

povidone-iodine 1

progesterone 1

proton pump inhibitors (PPI) 6

PUL-042 inhalation solution

radiotherapy

selinexor

statins

stem cells 3

TD-0903

TD-0903 10mg 1

TD-0903 1mg 1

TD-0903 3mg 1

thalidomide 1

tradipitant

tranilast

vitamin C 4

zinc plus vitamin c 1

zinc 3

respiratory support

vaccines

BCG vaccination

DNA vaccine

bacTRL-Spike

Follow-us

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N) and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

   

- About - Our approach - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons